Product NDC: | 68382-443 |
Proprietary Name: | ethosuximide |
Non Proprietary Name: | ethosuximide |
Active Ingredient(s): | 250 1/1 & nbsp; ethosuximide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68382-443 |
Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200892 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121010 |
Package NDC: | 68382-443-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (68382-443-01) |
NDC Code | 68382-443-01 |
Proprietary Name | ethosuximide |
Package Description | 100 CAPSULE in 1 BOTTLE (68382-443-01) |
Product NDC | 68382-443 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ethosuximide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20121010 |
Marketing Category Name | ANDA |
Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
Substance Name | ETHOSUXIMIDE |
Strength Number | 250 |
Strength Unit | 1/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |